Growth Metrics

Pacific Biosciences Of California (PACB) Profit After Tax Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.72%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 13.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -12.28%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 99.26%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 4.70%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 125.69%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 89.28%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -27.13%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 51.30%
10 Pacific Biosciences Of California 481.66 Mn 205.70 Mn 12.84 Mn 98.06%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 98.06%
Dec 31, 2025 -1,802.70%
Sep 30, 2025 37.42%
Jun 30, 2025 75.81%
Mar 31, 2025 -445.01%
Dec 31, 2024 102.89%
Sep 30, 2024 9.19%
Jun 30, 2024 -148.19%
Mar 31, 2024 11.18%
Dec 31, 2023 2.80%
Sep 30, 2023 13.12%
Jun 30, 2023 2.19%
Mar 31, 2023 -8.00%
Dec 31, 2022 -21.72%
Jun 30, 2022 -74.13%
Mar 31, 2022 6.79%
Dec 31, 2021 -192.52%
Jun 30, 2021 -77.60%
Mar 31, 2021 -7,028.29%
Dec 31, 2020 82,446.15%
Sep 30, 2020 18.59%
Jun 30, 2020 6.14%
Mar 31, 2020 104.16%
Dec 31, 2019 99.70%
Sep 30, 2019 -16.29%
Jun 30, 2019 -9.12%
Mar 31, 2019 -25.41%
Dec 31, 2018 -48.34%
Sep 30, 2018 -13.73%
Jun 30, 2018 11.74%
Mar 31, 2018 -1.31%
Dec 31, 2017 -9.10%
Sep 30, 2017 -25.88%
Jun 30, 2017 -38.06%
Mar 31, 2017 -23.33%
Dec 31, 2016 -1,250.60%
Sep 30, 2016 -1,060.68%
Jun 30, 2016 -55.00%
Mar 31, 2016 4.07%
Dec 31, 2015 92.57%
Sep 30, 2015 119.87%
Jun 30, 2015 37.63%
Mar 31, 2015 -6.81%
Dec 31, 2014 -10.12%
Sep 30, 2014 55.27%
Jun 30, 2014 6.52%
Mar 31, 2014 10.51%
Dec 31, 2013 20.48%
Sep 30, 2013 9.86%
Jun 30, 2013 8.97%
Mar 31, 2013 23.48%
Dec 31, 2012 5.06%
Sep 30, 2012 22.38%
Jun 30, 2012 0.78%
Mar 31, 2012 20.77%
Dec 31, 2011 37.51%
Sep 30, 2011 28.05%
Jun 30, 2011 30.72%